NCT06404320

Brief Summary

This is a pilot study examining the delivery of a remotely delivered, one-on-one, individualized physical activity (PA) program in adult participants with treatment-resistant depression (TRD).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 29, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 8, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

September 19, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

April 30, 2025

Status Verified

April 1, 2025

Enrollment Period

1.2 years

First QC Date

April 29, 2024

Last Update Submit

April 25, 2025

Conditions

Keywords

Major Depressive DisorderPhysical ActivityExercise

Outcome Measures

Primary Outcomes (3)

  • Feasibility

    Recruitment rate, withdrawal rate, adherence rate, and data completion rate

    13 weeks

  • Acceptability

    Responses to an exit survey

    13 weeks

  • Acceptability

    Responses to semi-structured qualitative interviews

    13 weeks

Secondary Outcomes (4)

  • Hamilton Depression Rating Scale-17

    13 weeks

  • Patient Health Questionnaire-9

    13 weeks

  • General Anxiety Disorder-7

    13 weeks

  • World Health Organization - Five Well-Being Index

    13 weeks

Other Outcomes (3)

  • Total duration of sleep; awake, light, rapid eye movement, and deep sleep durations

    13 weeks

  • Metabolic equivalent minutes

    13 weeks

  • Readiness (interpreted from sleep, activity, resting heart rate, heart rate variability, recovery index, and body temperature scores)

    13 weeks

Study Arms (2)

PA program

EXPERIMENTAL

Participants in the PA group will receive a 4-week remotely delivered one-on-one individualized PA program adjunct to TAU.

Behavioral: PA program - MoveU.HappyU

TAU

NO INTERVENTION

Participants in the TAU group will be given a handout with the Canadian 24-hour movement guidelines and be told that they are encouraged to engage in PA.

Interventions

Participants will meet with their program trainer once a week virtually for 4 weeks to engage in 30 minutes of behavioral change coaching and 30 minutes of a structured PA program that is tailored to their needs and goals. The intensity of the PA sessions will be self-selected. PA sessions will involve a warmup, a conditioning component consisting of individualized aerobic or resistance exercises, and a cool down/stretch. Participants will also be instructed to independently engage in PA (outside of their session with the trainer) for 120 minutes at 50-65% of their maximum work capacity. This can be done by engaging in PA between 3-5 times per week.

PA program

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sedentary adults (engage in less than 60 minutes of moderate-to-vigorous PA per week) between the ages of 18 and 65 years, inclusive, capable of giving informed consent.
  • Participants meeting diagnostic criteria for major depressive disorder without psychotic symptoms according to the Diagnostic and Statistical Manual of Mental Disorders - 5th Ed. and currently experiencing a major depressive episode (MDE) as confirmed by the Mini International Neuropsychiatric Interview (MINI).
  • A Montgomery-Åsberg Depression Rating Scale total score of ≥ 7 at screening (mild-to-severe MDE).
  • Failure of at least two trials of antidepressant therapy of adequate dose and duration during the current episode as established by the Antidepressant Treatment History Form and self-report.
  • Receiving treatments congruent with Canadian Network for Mood and Anxiety Treatments guidelines with no changes to treatments one month before screening (28 days).

You may not qualify if:

  • Current symptoms of mania, hypomania, mixed episodes, or psychosis.
  • Have received a diagnosis of alcohol or a substance use disorder within the past 3 months or as confirmed by the MINI. Other secondary psychiatric comorbidities (e.g., anxiety disorders, trauma-related disorders, etc.) will not be excluded.
  • Pregnant females.
  • Acute risk for a cardiovascular event (i.e., cardiovascular event in the past within the past 12 months).
  • Have any medical contraindications to exercise according to the Physical Activity Readiness Questionnaire.
  • Self-reported balance, gait, or locomotion difficulties that would preclude participation in a PA program.
  • Have any other condition that, in the opinion of the investigator(s), would adversely affect the subject's ability to complete the study or its measures.
  • Have exercise-induced asthma.
  • Taking medication that interferes with heart rate response to exercise, such as beta blockers.
  • Do not own a smartphone.
  • Do not have reliable access to the Internet.
  • Have previously received intravenous ketamine treatment in the last 2 months.
  • Non-English-speaking individuals are excluded because the ability to communicate study information, answer questions accurately and completely about the study, and obtain consent are necessary.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Michael's Hospital, Unity Health Toronto

Toronto, Ontario, Canada

RECRUITING

Related Publications (1)

  • Tassone VK, Quesnel DA, Parkington K, Rueda A, Martin J, Lee GH, Teixeira A, deJonge ML, Lou W, Wiljer D, Mulsant BH, Sabiston CM, Bhat V. Improving adherence to physical activity in treatment-resistant depression: Protocol for a pilot randomized controlled trial of a remotely delivered program. PLoS One. 2025 Sep 2;20(9):e0330848. doi: 10.1371/journal.pone.0330848. eCollection 2025.

MeSH Terms

Conditions

Depressive Disorder, Treatment-ResistantDepressive Disorder, MajorMotor Activity

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBehavior

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2024

First Posted

May 8, 2024

Study Start

September 19, 2024

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

April 30, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations